GNRH1 and endometriosis: DNG stands out in its class due to several distinguishing features, including the absence of systemic androgenic activity, good oral bioavailability, and the same effectiveness in controlling endometriosis‐associated pelvic pain compared with GnRH agonists.30, 31, 32, 33